| 8263583 |
Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide |
Paul Alan Glossop |
2012-09-11 |
$292,344,000 |
| 8013019 |
Sulfonamide derivatives for the treatment of diseases |
Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more |
2011-09-06 |
$533,448,000 |
| 7767715 |
Sulfonamide derivatives for the treatment of diseases |
Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more |
2010-08-03 |
$307,895,000 |
| 7629358 |
Compounds useful for the treatment of diseases |
Alan Daniel Brown, Charlotte Alice Louise Lane, Paul Alan Glossop, David Anthony Price, Russell Andrew Lewthwaite +2 more |
2009-12-08 |
$355,902,000 |
| 7612084 |
Amine derivatives for the treatment of asthma and COPD |
Lyn Howard Jones, David Anthony Price |
2009-11-03 |
$488,240,000 |
| 7547731 |
Formamide derivatives for the treatment of diseases |
Alan Daniel Brown, Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Paul Alan Glossop +1 more |
2009-06-16 |
$205,302,000 |
| 7538141 |
Compounds for the treatment of diseases |
Alan Daniel Brown, Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Paul Alan Glossop +1 more |
2009-05-26 |
|
| 7528170 |
Sulfonamide derivatives for the treatment of diseases |
Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more |
2009-05-05 |
$707,866,000 |
| 7351742 |
Sulfonamide derivatives for the treatment of diseases |
Alan Daniel Brown, Charlotte Alice Louise Lane, Ian Brian Moses, Nicholas Murray Thomson |
2008-04-01 |
$103,321,000 |
| 7244766 |
Sulfonamide derivatives for the treatment of diseases |
Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more |
2007-07-17 |
$333,650,000 |
| 7241810 |
Formamide derivatives for the treatment of diseases |
Alan Daniel Brown, Mark Edward Bunnage, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Paul Alan Glossop +1 more |
2007-07-10 |
$150,041,000 |
| 7214694 |
3-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitors |
Usa Datta, Paul Vincent Fish, Gavin Alistair Whitlock |
2007-05-08 |
$277,542,000 |
| 6897306 |
3-heterocyclylpropanohydroxamic acids |
Simon Bailey, Stephane Billotte, Paul Vincent Fish, Nicholas Murray Thomson, Andrew Michael Derrick |
2005-05-24 |
$583,482,000 |
| 6821972 |
3-heterocyclylpropanohydroxamic acid PCP inhibitors |
Simon Bailey, Paul Vincent Fish, Gavin Alistar Whitlock |
2004-11-23 |
$151,652,000 |
| 6716861 |
3-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitors |
Usa Datta, Paul Vincent Fish, Gavin Alistair Whitlock |
2004-04-06 |
$288,801,000 |
| 6448278 |
Procollagen C-proteinase inhibitors |
Simon Bailey, Stephane Billotte, Andrew Michael Derrick, Paul Vincent Fish, Nicholas Murray Thomson |
2002-09-10 |
$252,411,000 |
| 6384070 |
Indole derivatives useful as endothelin receptor antagonists |
David James Rawson, Kevin Neil Dack, Roger P. Dickinson |
2002-05-07 |
$456,476,000 |
| 6306852 |
Indole derivatives useful as endothelin receptor antagonists |
David James Rawson, Kevin Neil Dack, Roger P. Dickinson |
2001-10-23 |
$486,737,000 |
| 6211223 |
Indole derivatives useful in therapy |
Stephen Challenger, Kevin Neil Dack, Andrew Michael Derrick, Roger P. Dickinson, David Ellis +2 more |
2001-04-03 |
$932,933,000 |
| 6136843 |
Indole derivatives useful as endothelin receptor antagonists |
David James Rawson, Kevin Neil Dack, Roger P. Dickinson |
2000-10-24 |
$1,037,420,000 |
| 6017945 |
Indole derivatives useful as endothelin receptor antagonists |
David James Rawson, Kevin Neil Dack, Roger P. Dickinson |
2000-01-25 |
$352,913,000 |
| 4927819 |
Cyclo-octane neuroprotective agents |
Raymond Baker, William R. Carling, Paul D. Leeson |
1990-05-22 |
$63,323,000 |
